The Global Health 2030 group was created in October 2016. It brings together personalities who have long been involved in global health issues.
As an independent think tank, our aim is to produce, disseminate and promote ideas, analyses and recommendations that are likely to influence the public policies and strategies of French players in the field of global health.
Global Health 2030’s reflections are in line with the Sustainable Development Goals (SDGs), which set an international agenda for the fight against poverty, the protection of the planet and the search for prosperity by 2030.
What do we do?
Global Health 2030 aims to make recommendations on France’s global health policy and to mobilize all stakeholders to make health issues a strategic focus of French international aid.
We wish to defend issues that meet the essential needs of populations in countries with limited resources, and particularly those that mobilize the particular strengths and know-how of French global health actors.
Global Health 2030 wishes to engage in a dialogue with all the actors involved in the making of France’s international health policy, from public actors to private actors who share our conception of global health, as well as civil society partners and philanthropic organizations
Board and members
Louis PizarroSECRETARY GENERAL
Sana de CourcellesMEMBER
Annabel Desgrées du LoûMEMBER
Lelia Hernan MarmoraMEMBER
Anna Laura RossMEMBER
Françoise Barré-Sinoussi, a researcher involved in retrovirology research since the early 1970s, is known for her contributions in the field of AIDS, particularly the discovery of HIV in 1983.
Emeritus Research Director at the Institut National de la Santé et de la Recherche Médicale (INSERM), Honorary President of the international network of Pasteur Institutes, she has led work on the pathogenesis of HIV/AIDS, in particular on the mechanisms necessary to control HIV / SIV infections and/or the inflammation and deleterious activation of T lymphocytes induced in response to these infections.
Beyond her research activities, Françoise Barré-Sinoussi is an activist of multidisciplinary and translational research, and of international collaboration in response to the expectations of patients wherever they are in the world. In accordance with her commitments to capacity building and training in Africa and Southeast Asia, she has a long experience of collaboration with countries with limited resources, in relation to the international network of the Institut Pasteur and the coordination of ANRS AIDS research programs in Cambodia and Vietnam. In 2010, she launched the International AIDS Society (IAS) initiative “Towards a cure for HIV infection” as part of her strong involvement in advocacy to accelerate evidence-based public health interventions.
Françoise Barré-Sinoussi is author and co-author of more than 300 original publications and more than 125 articles in books. Invited to more than 400 international conferences and/or meetings, she was President of the IAS from 2012 to 2014 and remains a member and/or chair of numerous international scientific councils or advisory committees. Since 2009, she has been a member of the National Academy of Sciences in France. She has also received more than 40 national and international awards and distinctions, including the Nobel Prize in Medicine in 2008 for her contributions in the field of HIV/AIDS.
Officially retired, Françoise Barré-Sinoussi remains active on the international scene. President of Sidaction since November 2017, she currently chairs the ANRS Scientific Council and is still co-chair of the IAS initiative “Towards an HIV Cure”. Honorary President of the International Network of Pasteur Institutes, she will continue to play a major role in addressing global health challenges.
Louis Pizarro, a doctor, also holds a degree in international relations from Sciences Po Paris and an MBA from EHESP. He served as Head of Mission of Solthis in Niger before becoming Director General at the organization’s headquarters until 2020. Nowadays, he works in Geneva in an international organization.
He is also a lecturer in global health at Sciences Po Paris and Paris I Panthéon-Sorbonne.
Research Director at INSERM, Marie-Paule Kieny is also President of the Board of Directors of the Medicines Patent Pool Foundation and of DNDI (Drugs for neglected diseases initiative).
Dr Marie-Paule Kieny was appointed WHO Assistant Director-General for Health Systems and Innovation in November 2012. Since October 2010, she has held the same position for innovation, information, evidence and research. Previously, Dr Kieny had led the WHO Vaccine Initiative since its inception in 2001.
Among the significant successes achieved under her leadership was the development and licensing of new meningitis and pandemic influenza vaccines in developing countries through innovative transfers of technology and expertise.
Vaccines against diseases caused by poverty and diseases that affect mostly poor and marginalized populations have been her priorities since she joined the WHO’s Special Programme for Research and Training in Tropical Diseases in 2001.
Prior to joining the WHO, Dr Kieny held senior research positions in her home country, France, in the public and private sectors: Deputy Scientific Director of the Transgene Company from 1981 to 1988 and Director of Research and Head of the Molecular Virology Group for Hepatitis C Virus at the Institute of Virology, National Institute of Health and Medical Research (INSERM) from 1999 to 2000.
She holds a PhD in Microbiology from the University of Montpellier (1980) and a degree in Economics from the same university, as well as a habilitation to direct research from the University of Strasbourg (1995). Dr. Kieny has published more than 250 articles and studies, mainly in the field of infectious diseases, immunology and vaccinology.
Dr. Kieny was made Knight in the National Order of the Legion of Honor in 2016, Knight of the National Order of Merit by the French Ministry of Research in 2000, and received the Prix Génération 2000-Impact Médecin (1994) and the Prix de l’Innovation Rhône-Poulenc (1991).
After working five years as a doctor in a mother and child protection centre in Seine-Saint-Denis (La Courneuve), Paul Benkimoun turned to full-time medical journalism in 1988. He worked for ten years in the medical press before joining the editorial staff of the daily newspaper “Le Monde” in 1999, as an editor specialising in health issues. In addition to news, he covers epidemics and pandemics – particularly HIV/AIDS – and global health issues.
Since 2006, Paul Benkimoun has been working as a university teacher. From 2006 to 2015, he held an associate professorship at the University of Bordeaux Ségalen (2006-2015), which included teaching in the framework of the master’s degree “History, Philosophy and Mediation of Sciences” as well as in the preparation course for the journalism school competitions at the IEP of Bordeaux. Since 2010, he has been responsible for the “Communication on drug-related risks” component of the Eu2P European e-learning master’s degree “European program in Pharmacovigilance and in Pharmacoepidemiology” (teaching in English), which was initiated by the University of Bordeaux. In addition, he has also given lectures at Sciences Po Paris and the CNAM.
Paul Benkimoun is the author of several books in the field of medicine and health, as well as jazz. Among his books is “Morts sans ordonnance”, which recounts the global battle for access to medicines, culminating in the Doha Declaration adopted by the World Trade Organization (WTO).
Michel Cot is a physician and epidemiologist, doctor of science and research director at the IRD. He heads the “Populations: risks and interventions” team at UMR 216 IRD-University René Descartes “Mother and child facing tropical infections” (MERIT).
He has been working for thirty years on gestational malaria in sub-Saharan Africa (setting up and coordinating the monitoring of cohorts of pregnant women and exposed newborns, and clinical trials for the prevention of malaria during pregnancy). He has also worked on the genetic susceptibility of the human host to malaria, and has contributed to the discovery of genetic control of malaria infection levels in Cameroonian populations.
Michel Cot has been involved in the coordination of clinical trials in West Africa.
He is at the origin of the creation in 2015 of the Clinical Research Institute of Benin (IRCB). He has published nearly 150 scientific articles and is on the editorial board of the Malaria Journal. He is involved in teaching and student supervision activities. He sits on the scientific boards of many international projects and since 2006 he is an associate professor at Tulane University (USA).
He has been a member of the High Council of Public Health since 2016 and of the specialized commission “infectious and emerging diseases”.
Sana de Courcelles
Sana de Courcelles has been Health Counsellor at the Permanent Representation of France to the United Nations in Geneva since September 2019.
She has been Executive Director of the School of Public Affairs at Sciences Po, and an affiliated professor in the fields of State Reform and Health.
Since 2014 she has worked in the office of the Assistant Director-General of the World Health Organization (WHO), in charge of Health Systems and Innovation, in Geneva.
Previously, she was Parliamentary and Transversal Affairs advisor for the General Commissioner for Investment, in charge of investments for the future, Mr. René Ricol, and then Mr. Louis Gallois. She began her career as a strategy and organisation consultant in the public sector with Capgemini consulting.
François Dabis is a Doctor of Medicine, Professor of Epidemiology at the School of Public Health (ISPED) at the University of Bordeaux. He has more than 30 years of experience in research on HIV epidemiology and prevention and global health.
From 2001 to 2015, he led the research team on HIV in Africa of the INSERM Public Health Unit/Centre at the Institute of Public Health (ISPED). He is still a member of the two research teams on HIV and viral hepatitis (France and Africa) of the Inserm Centre U1219. His scientific interests focus on public health challenges, both in prevention and care approaches: prevention of mother-to-child transmission of HIV, cohort studies in adults and children on antiretroviral treatment, use of antiretroviral drugs for prevention as a means of controlling the epidemic. The research programme of Dr. Dabis and his team is being conducted in Aquitaine, France, West Africa, particularly in Côte d’Ivoire and South Africa.
François Dabis was President of Coordinated Action No. 12 of the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) from 2003 to 2015, in charge of the Agency’s scientific programme in countries with limited resources. From 2003 to 2012, he was President of the Scientific Council of the National Institute for Health Surveillance (INVS). To date, he has published 676 articles in international journals (Source: PubMed/Medline) and numerous book chapters and his H index is 66 (Source: Web of Science). François Dabis published at the end of 2012 as Coordinating Editor a reference book in French on Field Epidemiology.
François DABIS has been Director of the ANRS since March 2017.
Annabel Desgrées du Loû
Annabel Desgrées du Loû is a Director of Research in Demography at the Institut de Recherche pour le Développement (IRD).
After studying biology at the Ecole Normale Supérieure in Paris, she completed a thesis in demography on the impact of vaccinations on the health and mortality of children in Africa. Recruited then at the IRD, she conducted research on demographic and social issues in several fields of health: family planning, prevention of mother-to-child transmission of HIV/AIDS, HIV/AIDS prevention in vulnerable populations, the place of the disease in the migration process. Drawing on her dual training in biology and social sciences, she favours a multidisciplinary approach to health issues.
Currently working at the Population and Development Centre in Paris (CEPED, UMR IRD-University Paris Descartes), she is the head of the team “Health, Gender and Vulnerabilities in the South”, ERL INSERM 1244. She is Deputy Director of the Institut Convergence Migrations.
Eric Fleutelot is the Technical Director of the major pandemics division of Expertise France’s Health Department. In this capacity, he coordinates the 5% AIDS, Malaria and Tuberculosis Initiative.
He was previously Regional Advisor on Global Health in Southeast Asia, based at the French Embassy in Bangkok. For the French Ministry of Foreign Affairs and International Development, he supervised and monitored French investments in health in 10 South-East Asian countries, also liaising with scientific research, public health decision-makers and various French operators.
Until 2014, he was also Deputy Managing Director of Sidaction, where he contributed to the development of community programs for access to care and treatment mainly in Sub-Saharan Africa.
Eric Fleutelot has contributed to the development of innovative programmes, such as one for drug users in Nepal, in partnership with Nava Kiran Plus. He is also part of the team that set up the largest orphan support programme in Burundi, a country with almost 2000 children orphaned by AIDS.
Eric Fleutelot was made Knight of the National Order of Merit in 2007.
Frédéric Goyet is a doctor, specialist in public health, currently HIV-STI-Hepatitis Referent of the ARS Ile de France.
Previously, he was advisor for the international strategy of the director of GIP ESTHER, a French public organization for bilateral cooperation in the field of HIV/AIDS and health, which operates mainly through hospital partnerships. Frédéric began his career as a doctor in rural Ethiopia, Sudan and Cambodia for humanitarian organizations. In France, he managed a network of health professionals involved in the care of people living with HIV. He joined the Ministry of Health in 1996, and worked as a departmental medical inspector, in charge of HIV/AIDS prevention and care programmes, care for prisoners and the most vulnerable populations.
From 2001 to 2007, then from 2011 to 2012, he was seconded to the Ministry of Foreign Affairs, as advisor for HIV/AIDS and then as head of the health office at the Directorate General for Globalization. From 2008 to 2010, he was seconded to the European Commission, Directorate for Development Cooperation, as advisor for HIV/AIDS, access to medicines and relations with the Global Fund to Fight AIDS, Tuberculosis and Malaria.
He was then Policy Advisor to the Director of External Relations of the Global Fund to Fight AIDS, Tuberculosis and Malaria in Geneva, where he was more specifically in charge of monitoring the international processes that could affect the activity, or resources, of the Global Fund (G8, G20, post-2015 agenda, etc.), from 2013 to the end of 2016.
Michel Kazatchkine was appointed Special Envoy of the UN Secretary General on HIV/AIDS in Eastern Europe and Central Asia in July 2012. Professor Kazatchkine has dedicated the last 30 years to the fight against AIDS and global health as a physician, researcher, diplomat and administrator.
Professor Kazatchkine has been a member of numerous international boards and scientific committees. He was head of the ANRS (1998-2005) and chaired the WHO Strategic and Technical Advisory Committee on HIV/AIDS (2004-2007). From 2005 to 2007, Professor Kazatchkine was Ambassador in charge of the fight against HIV/AIDS and communicable diseases. In 2007, Professor Kazatchkine was elected Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, a position he held until March 2012.
Professor Kazatchkine holds Honorary Doctorates from the Imperial College in London, the Université Libre de Bruxelles and the Catholic University of Leuven. He is an Officer of the Legion of Honour and the National Order of Merit and Officer of National Orders of Senegal, Mali, Burkina Faso, Ivory Coast and Uzbekistan.
Mathieu Lamiaux is an Associate Director in the Paris office of the Boston Consulting Group. He is responsible for the Healthcare center of expertise in Western Europe and South America. Mathieu Lamiaux is also a key member of the Marketing, Sales & Pricing and Global Advantage Committee.
He also coordinates BCG’s Global Health activities in Europe and works closely with the WHO, the Global Fund and private partners in the fight against HIV/AIDS, tuberculosis and malaria.
A graduate of HEC Entrepreneurs, Mathieu Lamiaux previously worked for the Agence Française de Développement in Cameroon and Equatorial Guinea.
Lelia Hernan Marmora
A lawyer by training, Mr. Marmora has worked in several international organizations. For 7 years, he led health systems transformation projects in beneficiary countries at the World Bank.
In October 2014, Lelio Marmora was elected Executive Director of Unitaid, a position he held until March 2020.
Previously, during his 8 years at the Global Fund to Fight AIDS, Tuberculosis and Malaria, he served as Head of the Latin America and Caribbean Department and then as Director for Africa and the Middle East.
He has also worked for UNDP, UNESCO and the Inter-American Development Bank.
Mr. Marmora is a member of several boards of directors in the public and private sectors.
Benoit Miribel has been Secretary General of the Une Santé Durable pour Tous since June 2020. He was previously Director of Public Health at Institut Mérieux (2018-2020) and Managing Director of Fondation Mérieux (2007-2018).
Since June 2013, he has also been Honorary Chairman of Action contre la Faim (ACF), an association he chaired from 2010 to 2013 and directed from 2003 to 2006.
He has been President of the French Centre for Funds and Foundations (CFF) since June 2015.
Previously, he was Director General of the Bioforce Development Institute (1997/2002); Director of Communication and Development of Action Against Hunger (1995/1997) after having been in charge of programmes in Liberia, Angola, Burma, Bosnia, Cambodia, Laos and Mozambique. He started his professional activity at the Chamber of Commerce and Industry of Lyon (CCIL), within the Lyon St Exupéry Airport, as in charge of studies of international routes.
Since June 2015, Benoît Miribel has also been President of the Humanitarian Logistics Platform “Bioport” in Lyon. He is co-founder of the Forum Espace Humanitaire (FEH) and of the bilingual magazine, “Alternatives Humanitaires”, and a founding member of the association, Friendship France, which works in Bangladesh.
He co-authored with Alain Boinet in 2010, a report commissioned by the Minister of Foreign and European Affairs (B. Kouchner) on the evolution of humanitarian action and its challenges.
He was also a member of the High Council for International Cooperation (HCCI), of the White Paper Commission of the Ministry of Foreign Affairs (2008) and of the National Consultative Commission for Human Rights (1998-2001 and 2011- 2013).
Graduate of the IEP in Lyon, he also holds a DEA in International Relations from the University Paris Panthéon Sorbonne. He is a Knight of the Legion of Honor.
Olivier Nay is Professor of Political Science at the University Paris 1 Panthéon-Sorbonne, attached to the Centre d’études et de recherches administratives politiques et sociales (CNRS 8026). There, he directs the Master 2 program “Development and Humanitarian Action”. He was also a visiting professor at Columbia University in 2018 (New York).
He was Senior Adviser to the Global AIDS Coordinator at UNESCO, in partnership with the UNAIDS Programme (2003-07).
Olivier Nay has been a member of the Institut universitaire de France (2008-12), President of the Political Science Section of the National Council of Universities (2009-2015) and Vice-President of the Permanent Commission of the National Council of Universities (2011-15), Vice-President of the French Political Science Association (2010-16). He is currently a member of the Executive Committee of the International Political Science Association.
He is the author of numerous scientific publications on international organizations, development aid policies and the production of international development standards.
Anna Laura Ross
Anna-Laura Ross is currently Strategy Technical Manager at Unitaid.
She was previously responsible for the International Affairs and Scientific Relations Department at the ANRS. For this role, she led the development and implementation of the agency’s international scientific strategy. In particular, her duties included identifying and promoting partnerships with institutional bodies, such as research institutes, funding agencies, UN agencies and international health partnerships.
At the same time, Anna Laura Ross led the scientific and strategic coordination of the Towards an HIV cure programme for the IAS.
At the ANRS, she was previously head of the Vaccine Research Department and coordinated the agency’s HIV/AIDS vaccine development programme, working closely with the Scientific Programme Director. Prior to joining ANRS, Dr Ross was a postdoctoral researcher at the Medical Research Council LMB in Cambridge and at the Institut Pasteur where she conducted research on innate immune restriction mechanisms against HIV-1.
Anna-Laura Ross holds a PhD from the University of Cambridge as well as a degree in Global Health Policy from the London School of Hygiene and Tropical Medicine.
Benoit Vallet is a hospital practitioner, and was a University Professor at the Lille Regional University Hospital Centre from 1998 to 2013, as well as President of the Medical Commission of the establishment from 2010 to 2013. He was also Director General for Health from 2013 to 2018 at the Ministry of Social Affairs, Health and Women’s Rights and then at the Ministry of Solidarity and Health, and member of the Executive Board of the World Health Organization (WHO) from 2015 to 2018.
Since 2018, he is Senior Counsellor at the Court of Auditors (6th Chamber), and teacher at Sciences Po Paris.
Knowledge of health systems and national, European and international public health issues ;
Management of international health crises (Mers-Cov, Ebola, Zika) and various crises with an impact on the health system;
Improvement of the health system’s response to terrorist attacks;
Mobilization of national and international partners around public health issues: tobacco, drugs, international security, antimicrobial resistance, vaccination, strengthening of health systems, access to care.
Stephanie Tchiombiano is a graduate in political science and public health, as well as an associate lecturer in the political science department of Paris 1 Panthéon Sorbonne University. She is the pedagogical coordinator of the “Development and Humanitarian Aid” Master’s Degree.
She has worked more than fifteen years in the field of health in West Africa. First, and for eight years, seh was a delegate of the French Red Cross (in Niger, Togo, Mali, Chad, and Burkina Faso). Notably, she participated in the setting up of several outpatient treatment centres (CTA). She was then head of mission for the NGO Solthis in Niger, Mali and Guinea for another eight years, during which she worked mainly on access to antiretroviral drugs for HIV-positive patients and the strengthening of health systems. She then spent three years with FEI / Expertise France, for the 5% AIDS, Tuberculosis and Malaria Initiative, of which she was the coordinator.
She now divides her time between university teaching and the coordination of the “Global Health 2030” think tank.